Varex Imaging Corp is the issuer in an amended Schedule 13G reporting by Allspring Global Investments Holdings, LLC. Allspring reports beneficial ownership of 0 shares of Varex common stock, or 0.0% of the class, and reports zero sole and shared voting and dispositive power.
Varex Imaging Corp (VREX) shares reported by Pzena Investment Management, LLC as beneficially owned totaled 1,785,166 shares, or 4.2% of the class. Pzena reported sole voting power over 1,020,770 shares and sole dispositive power over 1,785,166 shares; shared voting and dispositive power were both zero. Pzena stated its clients have rights to dividends and sale proceeds, and no individual client’s interest exceeds 5% of the class.
Varex Imaging Corporation (VREX) has entered into an Agreement and Plan of Merger under which Teledyne Technologies will acquire Varex for $18.90 in cash per share, via a merger of Detect Merger Sub, Inc. into Varex, which will become a wholly owned subsidiary of Teledyne. A special meeting of stockholders will be held virtually on October 28, 2026 to vote on adopting the Merger Agreement, an advisory vote on merger-related executive compensation, and a possible adjournment to solicit additional proxies. Completion of the merger requires approval by holders of at least a majority of Varex’s outstanding common shares, expiration or termination of specified antitrust and foreign investment review periods, and other customary closing conditions; Teledyne has stated it will fund the transaction with cash on hand and credit-facility borrowings and has no financing condition. If completed, VREX shares will be delisted from Nasdaq, deregistered under the Exchange Act, and converted into the cash consideration (subject to appraisal rights under Delaware law); if the deal terminates in certain circumstances, Varex may owe Teledyne a $25.26 million termination fee.
Varex Imaging Corp (VREX) reported that Chief Financial Officer Shubham Maheshwari exercised 160,944 stock options on September 11, 2026 at an exercise price of $13.61 per share, receiving the same number of common shares. On the same day, 130,000 shares were sold at a weighted average price of $18.462 in a broker-assisted sell-to-cover transaction used solely to pay the option exercise price, related tax withholdings and broker fees, with all remaining shares from the exercise retained. The reported holdings include 2,137 shares acquired through the company’s 2017 Employee Stock Purchase Plan since the prior ownership report, and the options exercised were from a performance grant that finished vesting over four years ending in August 2025.
Varex Imaging Corp (VREX) director Jay K. Kunkel reported selling 8,121 shares of common stock on September 14, 2026 at $18.48 per share in an open-market or private transaction. After this sale, he directly holds 15,329 shares of Varex Imaging Corp, and no Rule 10b5-1 trading plan is reported.
Varex Imaging Corp (VREX) received a notice that director Jay K. Kunkel intends to sell common stock under Rule 144. The filing lists 8,121 shares of common stock associated with Fidelity Brokerage Services LLC and an indicated value of $150,076.08, to be sold on NASDAQ. The shares to be sold arise from restricted stock vesting events on February 11, 2024 (3,246 shares) and February 13, 2025 (4,875 shares), both granted as compensation by the issuer.
Varex Imaging Corp (VREX) is the issuer of common stock for which Shubham Maheshwari has filed a notice under Rule 144 to sell up to 130,000 shares through Fidelity Brokerage Services LLC. The filing lists an aggregate market value of approximately $2,400,074.59 for these shares and references 42,100,000 shares of this class as context for the class size. The planned sale is associated with a stock option exercise and is noted with an expected transaction date of September 11, 2026 on NASDAQ.
Varex Imaging Corporation (VREX) has called a special meeting to seek stockholder approval of a merger under which Teledyne Technologies, through Detect Merger Sub, will acquire Varex. Each share of Varex common stock will be converted into the right to receive $18.90 in cash, subject to withholding taxes, and Varex will become a wholly owned subsidiary of Teledyne, with its stock delisted from Nasdaq and deregistered under the Exchange Act.
The merger requires approval by the holders of a majority of Varex’s outstanding common shares, expiration or termination of U.S. HSR and specified foreign antitrust and UK NSIA reviews, and other customary conditions, including no Company Material Adverse Effect. The board unanimously recommends voting in favor of the merger, an advisory vote on merger-related executive compensation, and a possible adjournment to solicit additional proxies. Stockholders who do not vote for the merger and follow strict procedures may seek appraisal in Delaware court for the “fair value” of their shares. The agreement includes a no-shop with fiduciary-out for a Company Superior Proposal and a $25.26 million termination fee in specified circumstances; Evercore Group L.L.C. provided a fairness opinion for a fee tied largely to deal completion.
Varex Imaging Corp (VREX) reported equity compensation activity for Chief Human Resources Officer Karen L. Aranki. On August 14, 2026, 3,974 Restricted Stock Units vested and were converted on a one-for-one basis into 3,974 shares of common stock. Of these shares, 1,145 were withheld at a price of $18.49 per share to satisfy tax withholding obligations arising from the vesting. After this vesting, Aranki holds 3,975 Restricted Stock Units scheduled to vest 50% on August 15, 2026 and 50% on August 15, 2028, with vested shares to be delivered upon vesting.
Varex Imaging Corporation reported stronger results for the quarter ended July 3, 2026, with net revenues of $210.5 million, up from $203.0 million a year earlier. Net income attributable to Varex was $15.7 million versus a prior-year loss of $89.1 million, largely reflecting the absence of a $93.9 million goodwill impairment recorded in 2025. Diluted EPS was $0.37 compared with a loss of $2.15.
For the first nine months of fiscal 2026, revenue rose to $636.1 million from $615.7 million, and net income attributable to Varex improved to $9.9 million from a loss of $82.5 million. Operating cash flow declined to $3.4 million from $33.8 million, as inventories increased to $347.1 million. The company refinanced its debt, issuing a new $350.0 million Term Loan Facility and a $100.0 million Revolving Credit Facility, and redeemed the remaining $368.0 million of Senior Secured Notes, recognizing a $9.4 million loss on extinguishment.
Subsequent to quarter end, Varex agreed to be acquired by Teledyne Technologies Incorporated. Each outstanding Varex share will be converted into the right to receive $18.90 in cash, subject to stockholder approval, regulatory clearances, and other customary conditions. If completed, Varex will become a wholly owned subsidiary of Teledyne and its common stock will be delisted from Nasdaq.